Stay updated on Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.

Latest updates to the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check16 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check23 days agoChange DetectedThe page has been updated to include a new version number and a new download option, while the previous version of a clinical trial citation has been removed.SummaryDifference3%
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check59 days agoChange DetectedThe webpage has undergone significant changes regarding the clinical study of Lecanemab for Alzheimer's Disease, including the introduction of new dosage information and the removal of detailed study design descriptions. The revision number has also been updated.SummaryDifference27%
Stay in the know with updates to Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.